Stock Updates

AstraZeneca PLC (NYSE: AZN) – Is this large market cap stock undervalued?

AstraZeneca PLC (NYSE: AZN), is firmly in the large market cap category with market cap of 77924. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for AstraZeneca PLC is 30.76 (with a change from open of 1.17%), this in conjunction with a target price of 36.09. Volume today has so far reached 1952916, with an average volume of about 5858.25. The GAP for this stock, is -1.27%.

The P/E ratio is 35.08, bringing the forward P/E to a value of 10.55. The current EPS for AstraZeneca PLC, is 0.88, with a EPS growth for this year coming to a value of 128.90%. Performance has been interesting with performance year to date coming to -5.09%.

Looking further into the growth statistics for AstraZeneca PLC, EPS is looking like it will grow -11.86% in the next year. Looking even further it is projected to be -1.00%. Quarter over quarter is -100.40% for EPS growth and for sales growth quarter over quarter it is -11.20%. Looking at past EPS growth statistics we see that for the past five years it has been -16.70%. Sales growth for the past five years has in fact been -5.80%.

Looking at the ownership, we see that the insider ownership is at 0.50% and institutional ownership is 12.20%. Shares outstanding is 2530, while shares float is at a value of 2503.78. Float short for AstraZeneca PLC is 1.05% and the short ratio is 4.51.

In terms of debt, long term debt/equity is 1.22, while the total debt/equity comes to 1.3. The ability to meet these debts, means that the current ratio is 0.9, and the quick ratio is 0.8. The most recent gross margin is 82.20% and their operating margin is 15.00%. The profit margin is 9.20%.

AstraZeneca PLC has seen returns on assets of 3.70%, and on investment, 11.50%. Return on equity is 13.90%. Price/Earnings to growth ratio is *TBA. Price/Sales ratio is at a value of 3.24, with Price/book ratio coming to 5.76 and Price/cash is 16.77, and finally Price/Free cash Flow is *TBA.

The simple moving averages are -7.40% and 1.72% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -11.03% and the 52 week low is 15.59%.

AstraZeneca PLC has a dividend yield of 2.92%, with a current price of 30.76. The ability to pay this means the payout ratio is 108.10%. This is in an industry, Drug Manufacturers – Major, with equally high dividends from other companies in this sector, which it is Healthcare. AstraZeneca PLC is based in United Kingdom.

Performance in the Drug Manufacturers – Major industry means that AstraZeneca PLC has seen performance for the past week of -5.52%, with performance for the month coming to -5.93%. Looking at the data for the quarter it is at a value of 2.87%, and for the half year the performance is 2.94%. Volatility for this week is 1.17% and for the month this is 1.34%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment